LOS ANGELES, Feb. 10, 2011 — Young, uninsured stroke survivors or those covered by the Medicare Part D drug benefit often can’t afford medications — increasing the risk for future strokes or other cardiovascular disease-related events, accordi…
Tag Archives | medication
Stroke medicines still unaffordable for some survivors, according to University of Michigan research
Medication education key to successful adherence in patients with diabetes
Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego say that medication education is a key factor in helping patients with diabetes better stick to their drug treatments plans. The stu…
Anti-estrogen medication reduces risk of dying from lung cancer
A new study has found that tamoxifen, an anti-estrogen breast cancer medication, may reduce an individual’s risk of death from lung cancer. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study supports …
Faulty ‘off-switch’ stops children with ADHD from concentrating
Brain scans of children with attention-deficit/hyperactivity disorder (ADHD) have shown for the first time why people affected by the condition sometimes have difficulty in concentrating. The study, by experts at The University of Nottingham, …
Brain scans show children with ADHD have faulty off-switch for mind-wandering
Brain scans of children with attention-deficit/hyperactivity disorder (ADHD) have shown for the first time why people affected by the condition sometimes have such difficulty in concentrating. The study, funded by the Wellcome Trust, may explain why…
Autism breakthrough: Researchers identify possible treatment for impaired sociability
NORFOLK, Va. — Eastern Virginia Medical School researchers have identified a potential novel treatment strategy for the social impairment of people with Autism Spectrum Disorders (ASD), an aspect of the condition that has a profound impact on qual…
More than half of depression patients give up their treatment
Most patients who take anti-depressants give up their treatment in less than six months, the minimum period recommended for treating severe depression and other derived pathologies. This is the conclusion of a new study carried out by Catalan …
The color of medicine
According to recent research the color, shape, taste and even name of a tablet or pill can have an effect on how patients feel about their medication. Choose an appropriate combination and the placebo effect gives the pill a boost, improves outcomes…
Medication adherence improves blood pressure control in chronic kidney disease
CINCINNATI — Researchers at the University of Cincinnati (UC) and the Cincinnati Veterans Affairs (VA) Medical Center have found that about one-third of chronic kidney disease patients who are prescribed therapies for high blood pressure do not oft…
Improving health care in the Internet age
Faster and more widely available internet access has improved our lives in many ways but healthcare is lagging behind, according to researchers writing in the International Journal of Medical Engineering and Informatics.
The US team suggests that …
Low beta blocker dose can put patients at risk for subsequent heart attacks
CHICAGO — For nearly 40 years a class of drugs known as beta blockers have been proven to increase patients’ survival prospects following a heart attack by decreasing the cardiac workload and oxygen demand on the heart. In a breakthrough study rel…
No Link Between Genetic Ancestry, Asthma Response in African Americans
Genetic ancestry has no discernible influence on how African American patients with asthma respond to medication, according to a Henry Ford Hospital study. Researchers found that improved lung function in patients after taking inhaled steroids [...]
Use of medication for insomnia or anxiety increases mortality risk by 36 percent
Quebec City, September 9, 2010 — Taking medications to treat insomnia and anxiety increases mortality risk by 36%, according to a study conducted by Geneviève Belleville, a professor at Université Laval’s School of Psychology. The details of this…
Combining medication and psychosocial treatments may benefit patients with early-stage schizophrenia
Patients with early-stage schizophrenia who receive a combination of medication and a psychosocial intervention appear less likely to discontinue treatment or relapse — and may have improved insight, quality of life and social functioning — than t…
Study findings show value of dietary supplement SAMe in treatment of adults with major depressive disorders
BOSTON (August 31, 2010) — A new study conducted by investigators at Harvard Medical School and Massachusetts General Hospital (MGH) suggests that S-Adenosyl Methionine (SAMe), an over-the-counter dietary supplement, can be an effective, relativ…
Medication may slow progression of Alzheimer disease
A medication used to treat the symptoms of mild-to-moderate Alzheimer disease may actually do more – it may be able to delay progression of the disorder, according to a study conducted at the Indiana University School of Medicine. The study, which appears in the June issue of Archives of Neurology, enabled researchers to evaluate a change in cognition observed in patients who prematurely discontinued treatment with placebo or Exelon ? (rivastigmine tartrate), a medication prescribed for many patients.
Use of medication to treat pediatric insomnia is common, study finds
Despite a dearth of information about the use of medication for treating pediatric sleep disorders, about 75 percent of community-based pediatricians in a recent survey had recommended nonprescription medication, and more than 50 percent had prescribed a sleep medication to patients with difficulties falling and staying asleep.
New Tool To Help Consumers Reduce Medication Errors
The Agency for Healthcare Research and Quality and the National Council on Patient Information and Education today announced a new resource called Your Medicine: Play It Safe, to help consumers use prescription medicines safely. The 12-page brochure, available in English and Spanish, includes a detachable, pocket-sized medicine record form that can be personalized.
Arthritis drug suppresses cancer development by stopping action of key protein
Researchers have, for the first time, identified the molecular pathway by which a commonly prescribed arthritis medication inhibits the growth of cancer. Before this study, scientists had linked use of celecoxib capsules (commonly known as Celebrex) to prevention of cancer, but the way in which the medication acted in cancer cells was unknown. Now, investigators have found that celecoxib capsules stop a key transcription factor known as Sp1 from turning on multiple genes in cancer cells known to be associated with cancer growth.